The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial.
Masafumi OnoPly ChichareonMariusz TomaniakHideyuki KawashimaKuniaki TakahashiNorihiro KogameRodrigo ModoloHironori HaraChao GaoRutao WangSimon WalshHarry SuryapranataPedro Canas da SilvaJames CottonRené KoningIbrahim AkinBenno J W M RensingScot GargJoanna J WykrzykowskaJan J PiekPeter JüniChristian HammPhilippe Gabriel StegMarco ValgimigliStephan WindeckerRobert F StoreyYoshinobu OnumaPascal VranckxPatrick W J C SerruysPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2020)
The trial has been registered with ClinicalTrials.gov, Number NCT01813435.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- body mass index
- st elevation myocardial infarction
- acute myocardial infarction
- patients undergoing
- phase iii
- coronary artery disease
- study protocol
- coronary artery bypass grafting
- phase ii
- clinical trial
- open label
- atrial fibrillation
- physical activity
- randomized controlled trial
- heart failure
- weight gain
- left ventricular